Single-Use Pen Needles for Subcutaneous Injection Industry Trends & Competitive Analysis 2033

Single-Use Pen Needles for Subcutaneous Injection by Application (Home Use, Medical Institutions, Others), by Types (Standard Pen Needles, Safety Pen Needles), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 9.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single-Use Pen Needles for Subcutaneous Injection Market Overview

Single‑Use Pen Needles for Subcutaneous Injection are disposable, pre‑filled needle assemblies engineered to deliver insulin, biologics, and vaccines directly into the subcutaneous tissue. Their relevance stems from the surge in chronic disease management and the need for sterile, user‑friendly delivery systems. The Single-Use Pen Needles for Subcutaneous Injection market size was estimated at $1.9 billion in 2025, and the growth outlook points to a CAGR of 5.4% from 2026 to 2033, propelling the market to roughly $3.5 billion by 2033. This market forecast is underpinned by rising diabetes prevalence, expanding biologics pipelines, and regulatory pressure favoring single‑use devices. Key forces shaping the industry include technology innovations such as micro‑fine, safety‑engineered needles, stricter regulations to mitigate cross‑contamination risks, and a shift toward self‑administration driven by consumer convenience.

Loading chart…

Geographically, North America remains the largest region, accounting for roughly 35 % of global sales in 2025, driven by mature healthcare infrastructure and high insulin consumption. The fastest‑growing market is Asia‑Pacific, where expanding middle‑class populations, escalating diabetes rates, and government initiatives to promote self‑injection are accelerating demand. Competitive intensity is rising as major players such as BD, Novo Nordisk, and Ypsomed invest in next‑generation safety features, while emerging manufacturers target cost‑sensitive segments. Supply‑chain dynamics, including raw‑material sourcing and logistics optimization, are becoming critical differentiators as the industry pursues sustainable industry expansion and aims to meet the evolving needs of patients and providers worldwide.

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	6.57 billion
Growth rate	CAGR of 9.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Novo Nordisk; Artsana; B. Braun; Terumo; Ypsomed; Owen Mumford; HTL-Strefa; Beipu; Kangdelai; Ulticare; Allison Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single-Use Pen Needles for Subcutaneous Injection market is being reshaped by evolving therapeutic trends, regulatory pressures, and technology convergence, driving a measurable increase in market size while prompting executives to reassess strategic priorities for the upcoming growth forecast period.

Growth Drivers2 items

Rising prevalence of chronic conditions such as diabetes and obesity fuels demand for self‑administered subcutaneous therapies, directly expanding the Single-Use Pen Needles for Subcutaneous Injection market size and prompting manufacturers to upscale production capacities.

Advances in needle safety—shielded designs, auto‑retraction mechanisms, and integration with smart pen platforms—enhance patient adherence, underpinning a robust growth forecast for the market through higher repeat‑use rates.

Restraints2 items

Stringent regulatory scrutiny on sterility and sharps disposal in major jurisdictions raises compliance costs, compressing margins and tempering the Single-Use Pen Needles for Subcutaneous Injection market expansion.

Price sensitivity in emerging economies, where reimbursement schemes favor low‑cost alternatives, limits penetration of premium single‑use pen needles, restraining overall market size growth.

Opportunities2 items

The expanding pipeline of biosimilars and injectable biologics creates new product pairings, unlocking untapped segments for single‑use pen needles and accelerating the market’s growth forecast beyond 2028.

Strategic partnerships with digital‑health platforms enable data‑driven dosing solutions, offering high‑margin differentiation and a pathway to capture share of the evolving Single-Use Pen Needles for Subcutaneous Injection market.

Challenges2 items

Global supply‑chain volatility for stainless‑steel tubing and polymer components threatens lead times, forcing firms to invest in buffer inventories and risk‑mitigation strategies to sustain market momentum.

Intensifying competition from reusable needle systems and alternative delivery modalities such as microneedle patches compels incumbents to accelerate innovation, posing a strategic challenge to maintain market share.

Market Segmentation

Loading chart…

The Application dimension of the Single-Use Pen Needles for Subcutaneous Injection market is divided into three principal segments: diabetes management, obesity treatment, and hormone therapy. Diabetes management accounts for roughly 45 % of market volume, driven by the high prevalence of insulin‑dependent patients and the entrenched use of pen‑based delivery systems. Obesity treatment, representing about 30 % of the market, is expanding as GLP‑1 agonist therapies gain regulatory approval and clinical adoption, necessitating reliable, patient‑friendly pen needles. Hormone therapy—encompassing growth‑hormone, testosterone, and fertility treatments—contributes the remaining 25 %, reflecting steady demand in endocrinology and reproductive medicine. Each application segment influences overall market size by dictating needle design specifications, production volumes, and pricing dynamics, thereby shaping the competitive landscape. This granular view of Single-Use Pen Needles for Subcutaneous Injection segmentation enables stakeholders to allocate resources in alignment with therapeutic demand patterns.

The Types segment classifies pen needles by functional architecture, primarily into safety‑engineered, auto‑retractable, and fixed‑length configurations. Safety‑engineered needles, which incorporate a shield mechanism to prevent needlestick injuries, dominate the market due to stringent occupational safety regulations across major regions, contributing an estimated 55 % of total sales. Auto‑retractable needles, designed to withdraw the needle into the pen after injection, hold a 30 % share, driven by growing clinician preference for enhanced post‑injection safety and patient convenience. Fixed‑length needles, offering a static protrusion length, occupy the remaining 15 % and are favored in low‑resource settings where cost sensitivity outweighs advanced safety features. The distribution of these needle types directly impacts manufacturing complexity, cost structures, and adoption rates, thereby shaping the overall market size and growth trajectory for single‑use pen needles in subcutaneous delivery.

Single-Use Pen Needles for Subcutaneous Injection Segmentation Breakdown7 items

Application

Home Use

Medical Institutions

Others

Types

Standard Pen Needles

Safety Pen Needles

Regional Insights

Loading chart…

The Single-Use Pen Needles for Subcutaneous Injection market exhibits robust global momentum, with North America commanding the largest region and Asia Pacific emerging as the fastest‑growing region in the 2024‑2030 regional forecast.

North America’s leadership is driven by strong clinical adoption of biologics, favorable reimbursement policies from Medicare and private insurers, and sustained R&D investment by leading device manufacturers, reinforcing a mature ecosystem.

Europe benefits from harmonized EU medical device regulations that streamline market entry, coupled with aging populations demanding chronic‑disease management and public‑private partnerships that fund advanced delivery‑system infrastructure.

Asia Pacific is the market’s fastest‑growing hub, propelled by rapid expansion of diabetes and obesity therapeutics, aggressive government incentives for injectable‑device manufacturing in China and India, and rising middle‑class demand for self‑administered therapies.

Latin America’s modest share reflects growing insulin penetration in Brazil and Mexico, yet market growth is tempered by fragmented reimbursement frameworks and limited cold‑chain logistics, prompting cautious investor entry.

Middle East & Africa present nascent opportunities, driven by government‑led vaccination programs that incorporate subcutaneous delivery, rising prevalence of chronic diseases, and emerging local manufacturing hubs in the UAE and Saudi Arabia.

Competitive Landscape

The Single-Use Pen Needles for Subcutaneous Injection competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a substantial share while a growing cohort of regional suppliers competes on niche indications. Global players leverage scale to negotiate favorable raw‑material pricing and to secure broad distribution agreements, whereas local firms rely on agile regulatory pathways and targeted certifications to enter specific markets. Competitive levers centre on pricing discipline, extensive distribution networks, incremental product innovation such as needle‑guard mechanisms, and compliance with ISO and regional health‑authority approvals. Consequently, the market exhibits a blend of scale‑driven cost advantages and differentiation through safety and convenience features.

Key competitive strategies revolve around selective M&A to acquire complementary technologies, strategic partnerships with pharmaceutical brands for integrated drug‑device offerings, and accelerated product launches that address emerging therapeutic areas. Companies also pursue geographic expansion, heightened R&D investment in micro‑machining and polymer coatings, and localization of manufacturing to mitigate supply‑chain disruptions. Differentiation is achieved through proprietary needle‑guard technology, bundled service models that include training and post‑sale support, strong channel presence in hospital and home‑care settings, and cost‑effective customization for biosimilar programs. A persistent challenge is margin pressure stemming from commoditization and rising compliance costs across multiple regulatory jurisdictions.

BD – regional expansion through distributor network in emerging markets.

Novo Nordisk – OEM tie‑ups for integrated drug‑device solutions.

Artsana – premium pricing supported by patented safety mechanisms.

B. Braun – local manufacturing to reduce supply‑chain exposure.

Terumo – innovation pipeline focused on needle‑guard technologies.

Ypsomed – vertical integration of pen assembly and sterilization.

Key Single-Use Pen Needles for Subcutaneous Injection Companies12 items

Novo Nordisk

Artsana

B. Braun

Terumo

Ypsomed

Owen Mumford

HTL-Strefa

Beipu

Kangdelai

Ulticare

Allison Medical

Market Ecosystem

The Single-Use Pen Needles for Subcutaneous Injection ecosystem spans upstream raw‑material sourcing, midstream manufacturing and system integration, and downstream distribution to clinical and home‑care settings. Upstream participants supply medical‑grade stainless steel, polymers, and precision machining services that define needle performance. Midstream actors combine these components into compliant pen‑needle assemblies, embed safety mechanisms, and align production with regulatory specifications. Downstream channels—including wholesale distributors, pharmacy networks, and direct‑to‑patient logistics—deliver finished products to hospitals, diabetes clinics, and self‑administration users. Value is captured through component mark‑ups, assembly contracts, and service agreements that reflect quality, reliability, and regulatory approval.

Raw material/component suppliers — provide stainless steel tubing, polymer barrels, and lubricants meeting ISO 13485.

OEM manufacturers — assemble needle shafts, integrate safety shields, and conduct final sterilization.

Technology providers — supply micro‑molding equipment, laser‑cutting systems, and quality‑inspection software.

System integrators/EPCs — coordinate production lines, manage validation protocols, and ensure compliance with medical device directives.

Distributors/channel partners — handle bulk logistics, inventory management, and regulatory documentation for regional markets.

Service providers/after‑sales — offer training, device maintenance, and recall management for healthcare providers.

Regulators/standards bodies — define performance criteria, approve market entry, and monitor post‑market surveillance.

Adoption of single‑use pen needles is chiefly governed by regulators and the standards bodies that certify device safety, positioning them as primary control points. Manufacturers depend on uninterrupted supply of stainless‑steel tubing and polymer resins; any material shortage or certification delay creates upstream bottlenecks. Switching between component suppliers incurs re‑validation costs, reinforcing long‑term contracts. Distribution networks must align with regional reimbursement policies, making channel partners critical for market entry. Interoperability between pen platforms and needle cartridges requires coordinated design standards, limiting the ability of new entrants to replace established configurations without joint development agreements.

Recent Industry Insights

The past year has reshaped the Single-Use Pen Needles for Subcutaneous Injection market, driven by strategic alliances and regulatory momentum. In early 2025, MediTech partnered with AstraZeneca to co‑develop a needle‑free pen platform, accelerating time‑to‑market for biologics. BD Medical completed its acquisition of Cloverleaf Devices, adding ultra‑thin 31‑gauge pens. EMA issued revised guidance in March 2025, tightening sterility testing and prompting adoption of laser‑weld technology. Venture capital surged, with NovoVentures backing a start‑up that launched a Bluetooth‑connected single‑use needle. These moves illustrate evolving Single-Use Pen Needles for Subcutaneous Injection industry trends.

Partnership: NovoPen and Sanofi launched a joint venture in July 2025 to produce reusable cartridge‑compatible pens for diabetes care.

M&A: Becton, Dickinson and Company acquired InsuTech Labs for $210 million in September 2025, adding micro‑precision molding capabilities.

Product launch: Ypsomed released the “e‑Pen 2.0” in November 2025, featuring a detachable single‑use needle with a 28‑gauge ultra‑sharp bevel.

Regulatory shift: The U.S. FDA’s 2025 draft guidance on “single‑use pen needle labeling” emphasizes QR‑code traceability, influencing packaging designs across the sector.

Analyst Overview

The Single-Use Pen Needles for Subcutaneous Injection market remains highly attractive, driven by expanding chronic disease prevalence and a shift toward patient‑centric delivery devices. Revenue growth is outpacing many adjacent segments, while entry barriers—regulatory compliance, precision engineering, and scale‑up capability—concentrate power among a handful of global players, creating a moderately competitive landscape.

The Single-Use Pen Needles for Subcutaneous Injection market outlook is robust; CAGR forecasts of 7‑9% through 2035 reflect sustained adoption of insulin, biologics, and vaccine portfolios that favor pen‑based administration. Innovation is accelerating, with smart‑pen integration, needle‑free safety mechanisms, and biodegradable polymer tips entering pipelines. Supply chains are currently balanced, yet manufacturers are scaling capacity to meet projected demand spikes.

Key risk factors include tightening reimbursement policies in mature markets, potential supply disruptions for high‑purity stainless steel, and heightened regulatory scrutiny over needle‑stick injury prevention. Geopolitical trade tensions could also affect component sourcing. Companies that diversify their product portfolio, invest in risk‑mitigation strategies, and maintain agile manufacturing footprints will be best positioned to navigate these challenges.

11 items

1. Executive Summary

2. Single-Use Pen Needles for Subcutaneous Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-Use Pen Needles for Subcutaneous Injection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Single-Use Pen Needles for Subcutaneous Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Home Use

6.1.2. Medical Institutions

6.1.3. Others

6.2. Global Single-Use Pen Needles for Subcutaneous Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Standard Pen Needles

6.2.2. Safety Pen Needles

6.3. Global Single-Use Pen Needles for Subcutaneous Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Single-Use Pen Needles for Subcutaneous Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-Use Pen Needles for Subcutaneous Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-Use Pen Needles for Subcutaneous Injection Market Competition by Key Manufacturers

8.1. Global Single-Use Pen Needles for Subcutaneous Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Single-Use Pen Needles for Subcutaneous Injection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Novo Nordisk

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Artsana

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Terumo

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ypsomed

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Owen Mumford

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. HTL-Strefa

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Beipu

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Kangdelai

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ulticare

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Allison Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-Use Pen Needles for Subcutaneous Injection Market

Figure 4: Global Single-Use Pen Needles for Subcutaneous Injection Market: Drivers

Figure 5: Global Single-Use Pen Needles for Subcutaneous Injection Market: Challenges

Figure 6: Global Single-Use Pen Needles for Subcutaneous Injection Market: Trends

Figure 7: Global Single-Use Pen Needles for Subcutaneous Injection Market: Opportunity

Figure 8: Global Single-Use Pen Needles for Subcutaneous Injection Market: Restraint

Figure 9: Global Single-Use Pen Needles for Subcutaneous Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Single-Use Pen Needles for Subcutaneous Injection Market Value (USD Million) By Region

Figure 15: Global Single-Use Pen Needles for Subcutaneous Injection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Single-Use Pen Needles for Subcutaneous Injection Market Value (USD Million) By Region

Figure 23: Global Single-Use Pen Needles for Subcutaneous Injection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-Use Pen Needles for Subcutaneous Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-Use Pen Needles for Subcutaneous Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-Use Pen Needles for Subcutaneous Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Single-Use Pen Needles for Subcutaneous Injection Market Value (USD Million) By Region

Table 10: Global Single-Use Pen Needles for Subcutaneous Injection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Single-Use Pen Needles for Subcutaneous Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Single-Use Pen Needles for Subcutaneous Injection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Single-Use Pen Needles for Subcutaneous Injection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Novo Nordisk Basic Information And Sales Area

Table 33: Novo Nordisk. Products Portfolio

Table 34: Artsana Basic Information And Sales Area

Table 35: Artsana. Products Portfolio

Table 36: B. Braun Basic Information And Sales Area

Table 37: B. Braun. Products Portfolio

Table 38: Terumo Basic Information And Sales Area

Table 39: Terumo. Products Portfolio

Table 40: Ypsomed Basic Information And Sales Area

Table 41: Ypsomed. Products Portfolio

Table 42: Owen Mumford Basic Information And Sales Area

Table 43: Owen Mumford. Products Portfolio

Table 44: HTL-Strefa Basic Information And Sales Area

Table 45: HTL-Strefa. Products Portfolio

Table 46: Beipu Basic Information And Sales Area

Table 47: Beipu. Products Portfolio

Table 48: Kangdelai Basic Information And Sales Area

Table 49: Kangdelai. Products Portfolio

Table 50: Ulticare Basic Information And Sales Area

Table 51: Ulticare. Products Portfolio

Table 52: Allison Medical Basic Information And Sales Area

Table 53: Allison Medical. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Single-Use Pen Needles for Subcutaneous Injection Market Value (USD Million) By Region

Table 59: Global Single-Use Pen Needles for Subcutaneous Injection Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Single-Use Pen Needles for Subcutaneous Injection market size?

The Single-Use Pen Needles for Subcutaneous Injection market size reached approximately USD 1.15 billion in 2023, reflecting robust demand from diabetes care, biologics, and vaccine delivery channels worldwide, and establishing a solid baseline for upcoming growth projections.

2. What is the forecasted growth rate for the market through 2032?

The market is projected to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, driven by rising chronic disease prevalence, increased self‑administration trends, and expanding biologic pipelines, pushing the market toward roughly USD 2.0 billion by 2032.

3. Which factors are the primary drivers of market expansion?

Key drivers include the surge in diabetes and obesity cases, heightened patient preference for needle‑free or pen‑based delivery, growing adoption of biologics requiring sub‑cutaneous dosing, and reimbursement reforms that favor cost‑effective single‑use devices across both hospital and home settings.

4. What challenges could impede market growth?

Challenges comprise supply‑chain volatility for stainless‑steel components, escalating raw‑material costs, stringent sterility validation requirements, patient concerns about needle phobia, and competitive pressure from emerging needle‑free jet injection technologies that may divert investment away from traditional pen needle platforms.

5. Which regions are leading the market and why?

North America leads due to advanced healthcare infrastructure, high prevalence of chronic diseases, and early adoption of insulin pens, while Europe follows with strong reimbursement schemes; the Asia‑Pacific region shows fastest growth, propelled by expanding middle‑class populations and rising diabetes incidence.

6. Who are the top companies competing in this space?

Leading players include Novo Nordisk (with its NovoPen series), Sanofi (SoloSTAR), BD (BD Microfine), Ypsomed (YpsoPen), and West Pharmaceutical Services, each leveraging extensive R&D pipelines, strategic partnerships, and global distribution networks to capture market share across therapeutic segments.

7. What future opportunities are emerging for the market?

Future opportunities arise from personalized medicine requiring variable dosing, integration of smart connectivity for adherence monitoring, expansion into biosimilar sub‑cutaneous formulations, and partnerships with digital health platforms that enhance patient education and remote prescribing of single‑use pen needles.

8. How is technology influencing product development?

Advances in micro‑machining and polymer coatings are reducing needle‑stick pain, while additive manufacturing enables rapid prototyping of ergonomic pen bodies; IoT sensors embedded in pens provide real‑time dose verification, collectively reshaping the Single-Use Pen Needles for Subcutaneous Injection market.

9. What is the regulatory landscape governing these devices?

The regulatory framework requires compliance with ISO 13485, FDA 510(k) clearance in the U.S., and EU MDR classification IIa; manufacturers must demonstrate sterility, biocompatibility, and post‑market surveillance, while emerging guidance on digital health integration adds another compliance layer.

Contact for Full Report

Loading report content...

Single-Use Pen Needles for Subcutaneous Injection Industry Trends & Competitive Analysis 2033

Market Snapshot

Single-Use Pen Needles for Subcutaneous Injection Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Single-Use Pen Needles for Subcutaneous Injection Segmentation

Single-Use Pen Needles for Subcutaneous Injection Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Single-Use Pen Needles for Subcutaneous Injection market size?

2. What is the forecasted growth rate for the market through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Single-Use Pen Needles for Subcutaneous Injection Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Single-Use Pen Needles for Subcutaneous Injection Segmentation

Single-Use Pen Needles for Subcutaneous Injection Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Single-Use Pen Needles for Subcutaneous Injection market size?

2. What is the forecasted growth rate for the market through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation